RV

Rasilaben Vinubhai Kanani

Active Director Director DIN 10648229
DIN 10648229 First appointment May 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rasilaben Vinubhai Kanani

Data last updated:

Rasilaben Vinubhai Kanani is a Director at Amarvira Ayurvedic Private Limited (since 2024). The company operates in Paper.

DIN 10648229
Primary Designation Director
Industry Paper
First Appointment 29 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amarvira Ayurvedic Private Limited U21003GJ2024PTC151977
Director29 May 20242024Active

Board colleagues of Rasilaben Vinubhai Kanani

NameDINCompanyDesignation
Reshma Niravbhai Akabari10648230Amarvira Ayurvedic Private LimitedDirector

Directorship timeline

Open interactive timeline →
Amarvira Ayurvedic Private Limited
Premium access

Shareholding and investment profile for Rasilaben Vinubhai Kanani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rasilaben Vinubhai Kanani

Rasilaben Vinubhai Kanani currently holds 1 directorship: Amarvira Ayurvedic Private Limited (Director, since 29 May 2024).

Rasilaben Vinubhai Kanani was first appointed on 29 May 2024 as Director at Amarvira Ayurvedic Private Limited.

The current boards of Rasilaben Vinubhai Kanani's companies include Reshma Niravbhai Akabari (Amarvira Ayurvedic Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available